Antibodies specific for nucleic acid modifications.
RNA Biol. 14, 1-10 (2017)
Nucleotide modifications constitute marks in RNA and DNA that contribute to gene regulation, development and other cellular processes. The understanding of their intricate molecular roles has been hampered by the high number of different modifications, the lack of effective methods and tools for their detection and quantification as well as by their complex structure-function relationship. The recent development of RNA and DNA immunoprecipitation followed by high-throughput sequencing (RIP- and DIP-seq) initiated detailed transcriptome- and genome-wide studies. Both techniques depend on highly specific and sensitive antibodies to specifically enrich the targeted modified nucleotides without background or potential biases. Here, we review the challenges and developments when generating and validating antibodies targeting modified nucleotides. We discuss antibody-antigen interactions, different strategies of antigen generation and compare different binder formats suitable for state-of-the-art high resolution mapping and imaging technologies.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Antibody ; Epigenomics ; Epitranscriptomics ; Modified Nucleotide ; Nucleic Acid Modification; Messenger-rna Methylation; Dynamic N-1-methyladenosine Methylome; Embryonic Stem-cells; Dna Methylation; Monoclonal-antibody; Protein Antigens; Mapping Reveals; Cancer-patients; Mouse Embryo; Autoimmune Antibodies
Keywords plus
Language
english
Publication Year
2017
Prepublished in Year
HGF-reported in Year
2017
ISSN (print) / ISBN
1547-6286
e-ISSN
1555-8584
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 14,
Issue: 9,
Pages: 1-10
Article Number: ,
Supplement: ,
Series
Publisher
Landes Bioscience
Publishing Place
Philadelphia
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30201 - Metabolic Health
30203 - Molecular Targets and Therapies
Research field(s)
Helmholtz Diabetes Center
Immune Response and Infection
PSP Element(s)
G-502210-001
G-501500-004
Grants
Copyright
Erfassungsdatum
2017-06-07